Avadel Pharmaceuticals (AVDL) Assets (2016 - 2022)
Historic Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $145.8 million.
- Avadel Pharmaceuticals' Assets fell 4480.72% to $145.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $145.8 million, marking a year-over-year decrease of 4480.72%. This contributed to the annual value of $247.3 million for FY2021, which is 2065.61% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Assets of $145.8 million as of Q3 2022, which was down 4480.72% from $157.9 million recorded in Q2 2022.
- Avadel Pharmaceuticals' 5-year Assets high stood at $351.9 million for Q1 2018, and its period low was $145.8 million during Q3 2022.
- For the 5-year period, Avadel Pharmaceuticals' Assets averaged around $239.6 million, with its median value being $247.3 million (2021).
- As far as peak fluctuations go, Avadel Pharmaceuticals' Assets tumbled by 5065.61% in 2019, and later soared by 11017.33% in 2020.
- Avadel Pharmaceuticals' Assets (Quarter) stood at $190.3 million in 2018, then fell by 20.42% to $151.4 million in 2019, then soared by 105.79% to $311.6 million in 2020, then decreased by 20.66% to $247.3 million in 2021, then crashed by 41.05% to $145.8 million in 2022.
- Its last three reported values are $145.8 million in Q3 2022, $157.9 million for Q2 2022, and $221.1 million during Q1 2022.